Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00257465
Status:
COMPLETED
Last Update Posted:
2015-12-03
First Post:
2005-11-22
Brief Title:
Trial of Autologous Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma
Sponsor:
AVAX Technologies
Organization:
AVAX Technologies
Organization Data
Organization:
AVAX Technologies
Class:
INDUSTRY
Study ID:
A1000401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AVAX Technologies
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None